Table 5 Changes in medications among patients taking insulin at baseline, who completed the study
Participants | Medication at baseline | Medication at 24 weeks |
|---|---|---|
1 | metformin 2 g, glimepirid 3 mg, insulin 28 units | metformin 2 g, liraglutide 1.2 mg |
2 | metformin 2 g, glimepirid 3 mg, insulin 28 units | metformin 2 g, liraglutide 1.8 mg |
3 | metformin 0.85 g, insulin 140 units | metformin 1.7 g, liraglutide 1.2 mg |
4 | metformin 1,7 g, insulin 60 units | metformin 1.7 g, liraglutide 1.2 mg |
5 | metformin 1 g, insulin 100 units | metformin 1 g, liraglutide 0.6 mg |
6 | metformin 2 g, insulin 100 units | metformin 2 g, liraglutide 1.2 mg |
7 | metformin 2 g, insulin 40 units | metformin 2 g, liraglutide 1.2 mg |
8 | metformin 2 g, insulin 300 units | metformin 2 g, liraglutide 1.2 mg |
9 | metformin 1.7 g, insulin 64 units | metformin 1.7 g, liraglutide 1.2 mg |
10 | metformin 0.85 g, insulin 132 units | metformin 1.7 g, liraglutide 1.2 mg |
11 | metformin2 g, insulin 70 units | metformin 2 g, liraglutide 1.8 mg |
12 | metformin 1 g, insulin 72 units | metformin 1 g, liraglutide 1.2 mg |
13 | insulin 30 units | metformin 2 g, liraglutide 1.2 mg |